These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11363145)

  • 21. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
    Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
    J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [[ABC of the antivirals] Project Inform].
    Sidahora; 1996; ():19-32. PubMed ID: 11364292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel HIV strategies previewed.
    Smart T
    GMHC Treat Issues; 1996 Dec; 10(12):6-7. PubMed ID: 11364018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.
    Justesen US
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):20-31. PubMed ID: 16433887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1, 2, 3-current ways to fight HIV.
    Vazquez E
    Posit Aware; 1998; 9(6):31-3. PubMed ID: 11366478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic strategies towards HIV-1 infection in macrophages.
    Perno CF; Svicher V; Schols D; Pollicita M; Balzarini J; Aquaro S
    Antiviral Res; 2006 Sep; 71(2-3):293-300. PubMed ID: 16806514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy for HIV infection: what does it need to make it work?
    von Laer D; Hasselmann S; Hasselmann K
    J Gene Med; 2006 Jun; 8(6):658-67. PubMed ID: 16598816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy.
    Sarmati L; Nicastri E; Montano M; Dori L; Buonomini AR; d'Ettorre G; Gatti F; Parisi SG; Vullo V; Andreoni M
    J Med Virol; 2004 Apr; 72(4):511-6. PubMed ID: 14981751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress and prospects: RNA-based therapies for treatment of HIV infection.
    Scherer L; Rossi JJ; Weinberg MS
    Gene Ther; 2007 Jul; 14(14):1057-64. PubMed ID: 17607313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy as an adjunct to highly-active antiretroviral therapy.
    Murphey-Corb M; Heydenburg-Fuller D
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1191-7. PubMed ID: 11717803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Summaries from the Eleventh Annual Houston Conference on AIDS in America.
    Res Initiat Treat Action; 1999 Jul; 5(3):13-25. PubMed ID: 11366719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral update: recent advances expand options for patients with HIV.
    Santhanam H; Goins M
    Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
    [No Abstract]   [Full Text] [Related]  

  • 34. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.
    Akkina R; Banerjea A; Bai J; Anderson J; Li MJ; Rossi J
    Anticancer Res; 2003; 23(3A):1997-2005. PubMed ID: 12894572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.
    Joly V; Yeni P
    Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving immune function and controlling viral replication in HIV-1-infected patients with immune-based therapies.
    Angel JB
    AIDS Read; 2001 Apr; 11(4):209-21. PubMed ID: 11392678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetically modified immunocompetent cells in HIV infection.
    Palù G; Li Pira G; Gennari F; Fenoglio D; Parolin C; Manca F
    Gene Ther; 2001 Nov; 8(21):1593-600. PubMed ID: 11894997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy.
    Li M; Li H; Rossi JJ
    Ann N Y Acad Sci; 2006 Oct; 1082():172-9. PubMed ID: 17145937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.
    Gondois-Rey F; Biancotto A; Fernandez MA; Bettendroffer L; Blazkova J; Trejbalova K; Pion M; Hirsch I
    J Virol; 2006 Jan; 80(2):854-65. PubMed ID: 16378987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Approaches to pathogenetic immunotherapy of HIV-infections].
    Nikol'skiĭ IS; Iurchenko VD
    Lik Sprava; 2002; (7):7-14. PubMed ID: 12587295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.